WallStSmart
SRRK

Scholar Rock Holding Corp

NASDAQ: SRRK · HEALTHCARE · BIOTECHNOLOGY

$46.61
+0.67% today

Updated 2026-04-30

Market cap
$5.57B
P/E ratio
P/S ratio
13.14x
EPS (TTM)
$-3.29
Dividend yield
52W range
$27 – $52
Volume
1.6M

WallStSmart proprietary scores

23
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D
6.0
Quality
B
3.0
Profitability
D
5.0
Valuation
C+
2/9
Piotroski F-Score
Weak
-2.2
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$57.73
+23.86%
12-Month target
Intrinsic (DCF)
Margin of safety
3 Strong Buy13 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Debt/equity 0.45x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -2.20 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-75.53M
- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$33.19M$0.00$0.00$0.00$0.00
Net income$-131.65M$-165.79M$-246.29M$-377.94M$-90.97M
EPS$-3.29
Free cash flow$-133.76M$-145.30M$-201.05M$-300.64M$-75.53M
Profit margin-396.61%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
SRRK$5.57B233.73.05.06.0Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Scholar Rock Holding Corp trades at $46.61. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -2.20, it sits in the distress.

Frequently asked questions

What is Scholar Rock Holding Corp's stock price?
Scholar Rock Holding Corp (SRRK) trades at $46.61.
Is Scholar Rock Holding Corp overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell).
What is the price target of Scholar Rock Holding Corp (SRRK)?
The analyst target price is $57.73, representing +23.9% upside from the current price of $46.61.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
-2.20 — distress.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio13.14x
ROE-123.10%
Beta0.69
50D MA$46.14
200D MA$40.05
Shares out0.12B
Float0.10B
Short ratio
Avg volume1.6M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years